Although purinergic compounds are widely involved in the intra-and intercellular communication of the nervous system, little is known of their involvement in the growth and regeneration of neuronal connections. In dissociated cultures, the addition of adenosine or guanosine in the low micromolar range induced goldfish retinal ganglion cells to extend lengthy neurites and express the growth-associated protein GAP-43. These effects were highly specific and did not reflect conversion of the nucleosides to their nucleotide derivatives; pyrimidines, purine nucleotides, and membrane-permeable, nonhydrolyzable cyclic nucleotide analogs were all inactive. The activity of adenosine required its conversion to inosine, because inhibitors of adenosine deaminase rendered adenosine inactive. Exogenously applied inosine and guanosine act directly upon an intracellular target, which may coincide with a kinase described in PC12 cells. In support of this, the effects of the purine nucleosides were blocked with purine transport inhibitors and were inhibited competitively with the purine analog 6-thioguanine (6-TG). In PC12 cells, others have shown that 6-TG blocks nerve growth factor-induced neurite outgrowth and selectively inhibits the activity of protein kinase N, a partially characterized, nerve growth factor-inducible serine-threonine kinase. In both goldfish and rat retinal ganglion cells, 6-TG completely blocked outgrowth induced by other growth factors, and this inhibition was reversed with inosine. These results suggest that axon outgrowth in central nervous system neurons critically involves an intracellular purine-sensitive mechanism.
Under normal circumstances, neurons in the adult mammalian central nervous system fail to regenerate axons injured by stroke or trauma, resulting in long lasting disabilities in sensory, motor, or cognitive functions. However, many central nervous system neurons have the potential to regrow their axons if exposed to appropriate growth factors and/or if inhibitory influences that normally prevail in the mature central nervous system are suppressed (1) (2) (3) . To identify factors that foster axonal regrowth in the central nervous system, we have turned to the classic model of optic nerve regeneration in lower vertebrates. Following injury to the optic nerve, retinal ganglion cells (RGCs) 1 in fish and amphibia re-extend axons that synapse upon appropriate central targets within 1-2 months (4) . In a dissociated cell culture model of this system, two factors secreted by optic nerve glia were found to be responsible for inducing axon outgrowth from goldfish RGCs (5, 6) . The more potent of these, axogenesis factor-1 (AF-1), has a molecular mass Ͻ1 kDa and stimulates lengthy axonal outgrowth without altering cell survival. AF-2 is a larger polypeptide that exerts a significant but less pronounced effect than AF-1. The specificity of these effects is demonstrated by the inactivity of a host of polypeptide growth factors or low molecular mass differentiation factors in this system (5) .
In the present study, we have investigated the role of purines in the regeneration of RGC axons. Although the involvement of purine nucleosides in the intra-and intercellular signaling of the nervous system is well established, their role in axonal outgrowth has not been investigated extensively. Extracellularly, many nerve terminals release adenosine or ATP as cotransmitters that act via P 1 or P 2 purinergic receptors to mediate changes in ion fluxes and other physiological effects in target cells (7) (8) (9) (10) (11) . In PC12 pheochromocytoma cells, purines partially mimic or augment the effects of nerve growth factor (12) , whereas in sympathetic neurons, adenosine inhibits neurite outgrowth and induces apoptotic cell death (13) . We show here that, in dissociated retinal ganglion cells, inosine and to a lesser extent guanosine act directly upon an intracellular pathway to stimulate axonal outgrowth and expression of the growth-associated protein GAP-43, whereas the purine analog 6-thioguanine acts competitively with these purines to arrest growth.
EXPERIMENTAL PROCEDURES
Dissociated Retinal Cultures-Goldfish (Comet Variety, Mt. Parnell Fisheries, Mt. Parnell, PA), 6 -10 cm in length, were dark-adapted, and their retinas were dissected. Retinas were incubated with papain (20 g/ml) activated with cysteine (2.8 mM) for 30 min at room temperature, and then dissociated by gentle trituration. Repeated cycles of trituration and sedimentation yielded cultures nearly homogeneous in ganglion cells, which are readily identified by their oval shape, phasebright appearance, size (diameter ϭ 12-25 m), and extension of 1 or 2 neurites of uniform caliber; these criteria have been verified by retrograde labeling (5, 14) . Low density cultures were obtained by plating ϳ5 ϫ 10 3 cells/well in poly-L-lysine coated, 24-well culture dishes (Costar, Cambridge, MA). Cells were maintained at 21°C in a serumfree, defined medium as described (5, 6) . Dissociated cultures of purified rat retinal ganglion cells were prepared by immunopanning (15) . Briefly, retinas from postnatal day 8 Sprague-Dawley rats were dissociated enzymatically, and macrophages were removed by incubation with an anti-rat macrophage antibody (Accurate) followed by immunopanning with an anti-rabbit IgG antibody. Ganglion cells were separated from non-adhering cells by immunopanning with an anti-Thy-1 antibody (American Type Culture Collection) and then dislodged with trypsin. RGCs of Ͼ95% purity were maintained at 37°C in a 5% CO 2 incubator in the same medium used for goldfish RGCs except for the addition of 5 M forskolin to enhance cell viability (16) and 26 mM bicarbonate. Based upon other studies (17) , stimulation of growth by recombinant rat ciliary neurotrophic factor (CNTF; 20 ng/ml, Promega, Madison, WI) was used as a positive control.
Experimental Design-Samples were plated in quadruplicate in randomized positions of a 24-well plate. To ensure that scoring was conducted blind, the code was concealed until experiments were completed. All experiments included 4 wells of a negative (defined medium only) and a positive control (partially purified AF-1, 20 -30% concentration). Growth and survival were assessed after 6 days by examining 15-25 consecutive fields of each well using phase contrast microscopy (at 400ϫ magnification, ϳ150 ganglion cells/well). Extension of a process at least 5 cell diameters in length was used as our criterion for outgrowth (5) . Means and standard errors were calculated (Cricket Graph, CA Associates, Islandia, NY), and data were normalized by subtracting the growth in the negative controls (usually 4 -5%) and dividing by the net growth in the positive controls. In the most favorable experiments, Ͼ50% of RGCs exposed to AF-1 for 6 days extended axons at least 5 cell diameters in length, and many were several hundred microns in length. At longer intervals, almost all AF-1-treated ganglion cells extend lengthy axons. 2 Group comparisons reported here are based upon pairwise, two-tailed Student's t tests. Several independent experiments were performed for all samples. In some cases, cell viability was assessed using the vital dye 5,6-carboxyfluorescein diacetate. For this, medium was replaced just prior to counting with a 0.005% (w/v) solution of carboxyfluorescein diacetate in PBS for 5 min. Cells were rinsed with PBS, and the fluorescent reaction product was visualized under UV illumination. Survival is reported as the number of viable RGCs/400ϫ field. Experiments using rat RGCs were carried out in a similar fashion except that cells were fixed and counted after 2 days. Outgrowth is reported as the fold increase in growth relative to negative controls.
Samples-Adenosine, AMP, adenosine deaminase (ADA), ADP, ATP, 8-bromo 3Ј,5Ј-cyclic guanosine monophosphate, cAMP, cGMP, cytidine, guanosine, hypoxanthine, inosine, 5Ј-inosine monophosphate, ␣-tocopherol, 6-thioguanine (6-TG), thymidine, and uridine were from Sigma. 8-p-Sulfophenyl-theophylline, dibutyryl cAMP, and deoxycoformycin (DCF) were from Calbiochem; 2-chloroadenosine (2-CA) and erythro-9-(2-hydroxy-3-nonyl) adenine were from Research Biochemicals, Inc. (Natick, MA); and 4-(nitrobenzyl-6-thioinosine) (NBTI) was from Aldrich. Membrane-permeable, nonhydrolyzable analogs of cAMP and of cGMP were from Biolog. The specific inhibitor to mitogen-activated protein kinase kinase-1 and -2 (MEK-1 and -2), PD 098059, and the inhibitor to phosphatidylinositol (PI) 3-kinase, LY 294002, were from Sigma. In experiments using these, RGCs were pretreated with inhibitors overnight prior to introducing growth factors. Thereafter, half the medium was changed daily for 5 days to maintain high concentrations of growth factors and inhibitors. Because PD 098059 and LY 294002 The effect of ADA on guanosine was not tested. ***, p Ͻ 0.001.
were prepared in Me 2 SO, positive and negative controls contained Me 2 SO at the concentration required to solubilize the drugs (0.6% final).
GAP-43 Immunostaining-Recombinant GAP-43 was made by transforming Escherichia coli with a zebrafish cDNA isolated by Dr. Eva Reinhard (18) subcloned into the prokaryotic expression vector pTrcHisB (Invitrogen). The protein was purified by Ni 2ϩ -nitrilotriacetic acid affinity chromatography and used to immunize rabbits. Prior to use, nonspecific binding of the antiserum was reduced by diluting it 1:1000 in 50 mM PBS containing 1% bovine serum albumin (Sigma) and reacting it at 4°C with a 1 ϫ 14-cm strip of a Western blot on nitrocellulose membrane containing ϳ200 g of proteins from goldfish internal organs separated by SDS-polyacrylamide gel electrophoresis. The specificity of the pre-adsorbed antibody is demonstrated on Western blots, where it reacts only with a 48-kDa band that is enriched in retinal ganglion cells undergoing regeneration (see below). Immunostaining was carried out in cultured neurons fixed in methanol (10 min, 4°C) and reacted overnight (4°C) with the immune serum prepared as described above or with non-immune serum. Cells were washed with PBS (3 ϫ 10 min), reacted with fluorescein isothiocyanate-conjugated antirabbit IgG (Jackson Immuno Research; 1:500 in PBS with 1% bovine serum albumin), and washed three times. For Western blots, ϳ10 6 goldfish retinal cells were grown in 100-mm dishes in control medium, AF-1 (30%), or inosine (50 M) for 6 days. Cells were collected and centrifuged, and 50 g of protein from each was separated by SDSpolyacrylamide gel electrophoresis (14% acrylamide), transferred to polyvinylidene difluoride membrane (200 mA, 15 h, 4°C), and probed for GAP-43 in a procedure similar to that used for immunocytochemistry except for the use of a horseradish peroxidase-conjugated secondary antibody followed by ECL reagent (Amersham Pharmacia Biotech). (5, 6) , AF-1, a low molecular mass growth factor secreted by optic nerve glia, stimulated extensive outgrowth from goldfish retinal ganglion cells (Fig. 1a) ; controls maintained in the absence of AF-1 remained quiescent (Fig. 1b) . At 100 M, adenosine and guanosine stimulated considerable outgrowth (Fig.  1c) , whereas the pyrimidines cytidine, uridine, and thymidine had no activity. These results are shown quantitatively in Fig.  2a , with data normalized by the net growth in AF-1-treated positive controls. A more complete dose-response curve (Fig.  2b ) shows that at 50 -100 M adenosine induces a response 60% of that stimulated by AF-1 but that outgrowth decreases at higher concentrations. Based upon 10 independent experiments, the EC 50 for adenosine was calculated to be 11.7 Ϯ 1.3 M (mean Ϯ S.E.). Guanosine was less potent (EC 50 ϭ 32.4 Ϯ 13.2 M, based upon five experiments), but at concentrations above 100 M, it stimulated the same maximal level of outgrowth as adenosine, with no decrease in activity at higher concentrations. None of these agents altered cell survival (see below, Fig. 3c) .
RESULTS

Purines Nucleosides Stimulate Axonal Outgrowth from Goldfish Retinal Ganglion Cells-In agreement with previous findings
Purine Nucleotides Are Less Active than Nucleosides-cAMP and ATP at concentrations of 1-100 M had no effect on outgrowth (Fig. 2c) . AMP and ADP were both inactive at 1 and 10 M but showed slight activity at 100 M (p ϭ 0.05). These results make it unlikely that the purine nucleosides are acting as precursors to nucleotides that stimulate P 2 purinergic receptors (10, 11) .
Another possibility is that the purines could serve as precursors for cyclic nucleotides that act as second messengers to stimulate outgrowth. However, nonhydrolyzable, membranepermeable analogs of cAMP (8-bromoadenosine-3Ј,5Ј cyclic monophosphorothioate) and of cGMP (8-(4-chlorophenylthio) guanosine-3Ј,5Ј-cyclic monophosphate) were inactive even at concentrations up to 1 mM (Fig. 2d) . Two other cyclic nucleotide analogs, dibutyryl cAMP and 8-bromo-cGMP, likewise showed no activity (Fig. 2d) . As with the nucleosides and other nucleotides, none of the cyclic nucleotides affected cell survival (data not shown).
Blockade of Adenosine Receptors-The two most common adenosine receptors (A 1 and A 2 ) are effectively blocked with 20 M 8-p-sulfophenyl-theophylline (19, 20) . However, this concentration of 8-p-sulfophenyl-theophylline had no effect on outgrowth stimulated by adenosine or guanosine (Fig. 3a, lanes 4  and 6) . A further indication that adenosine is not inducing growth through extracellular adenosine receptors comes from studies using the non-hydrolyzable analog, 2-CA, which acts as an agonist at the A 1 , A 2 , and A 3 receptors (21). At 10 and 100 M, 2-CA actually caused growth to decline below base line (Fig. 3a, lane 7 ; decline significant at p Ͻ 0.001).
Adenosine Must Be Hydrolyzed to Stimulate OutgrowthThe previous results indicate that adenosine must be metabolized to be active. Adenosine is converted to inosine by ADA (22) , and we therefore investigated the effects of inhibiting this enzyme with either DCF (10 M) or erythro-9-(2-hydroxy-3-nonyl) adenine (10 M). In the presence of DCF, 100 M adenosine caused growth to decline below base line (Fig. 3b , lane 5 versus lane 4: p Ͻ 0.01) and impaired cell survival (Fig. 3c , lane 5 versus lane 4: p Ͻ 0.001). These effects can be attributed specifically to nonhydrolyzed adenosine and did not occur when DCF was used alone, with AF-1, or with guanosine (Fig. 3, b   FIG. 4 . Inosine stimulates axonal outgrowth through an intracellular mechanism. a, at concentrations above 50 M, inosine stimulates about 60% the maximal level of growth activated by AF-1; its EC 50 is estimated to be 11.4 Ϯ 1.4 M. Hypoxanthine is inactive, whereas 5Ј inosine monophosphate (IMP) is an order of magnitude less active than inosine. b, at 20 M, NBTI, an inhibitor of purine transport, prevents inosine (ino) or guanosine (guo) from stimulating growth (100 M) but does not alter the effects of AF-1. ***, differences significant at p Ͻ 0.001. and c, lanes 2 and 8). Like DCF, erythro-9-(2-hydroxy-3-nonyl) adenine prevented 100 M adenosine from stimulating growth and caused cell survival to decline by 30% (data not shown). Further evidence that the effects of adenosine require its hydrolysis comes from experiments in which we added exogenous ADA. At 0.4 unit/ml, ADA failed to diminish axon growth stimulated by 100 M adenosine (Fig. 3b, lane 6 ) and had no effect on survival.
Inosine Is the Active Metabolite-As anticipated, inosine, the primary product of adenosine deamination, was a potent activator of axon outgrowth. The EC 50 for inosine was estimated to be 11.4 Ϯ 1.4 M (average from seven experiments), and a maximal response equal to about 60% the level stimulated by AF-1 was attained at concentrations of 50 M (Fig. 4a) . Unlike adenosine, increasing the concentration of inosine up to 1 mM did not cause growth to decline. Metabolic hydrolysis of inosine yields hypoxanthine, which was inactive. Inosine 5Ј monophosphate had no effect at 10 M but showed modest activity at 100 M (Fig. 4a) .
Purine Nucleosides Stimulate Growth through an Intracellular Pathway-Two inhibitors of purine transport, NBTI and dipyridamole, were used to investigate whether inosine and guanosine must be transported into neurons to stimulate growth. At 20 M, NBTI prevented both nucleosides from stimulating outgrowth (Fig. 4b, lanes 4 and 6 versus lanes 3 and 5, respectively; p Ͻ 0.01) but had little effect on AF-1-induced growth (lanes 1, 2) . Dipyridamole (10 M) likewise blocked the effects of inosine completely (p Ͻ 0.01; guanosine not tested).
Effect of Cell Density-The cultures used here contain 70 -90% ganglion cells, with the remainder representing other neural and non-neuronal elements of the retina (5, 14) . This heterogeneity raises the possibility that inosine or guanosine could act upon another cell type that secretes a secondary factor that stimulates RGCs. In this case, the effect of the purines would vary with cell density, because the concentration of any secondary factor should decrease as cell density declines. However, the level of outgrowth stimulated by either 100 M inosine or 100 M guanosine remained unchanged over a 10-fold density range, down to 5 cells/mm 2 (data not shown). GAP-43 Expression-A hallmark of optic nerve regeneration in vivo is the dramatic up-regulation in expression of the phosphoprotein, GAP-43 (23) (24) (25) . To investigate whether purine nucleoside stimulation mimics this up-regulation, we carried out immunohistochemistry using an antiserum against zebrafish GAP-43. As shown in Fig. 5 (c, e, and g ), AF-1, inosine, and guanosine all dramatically altered GAP-43 expression relative to negative controls. This is also evident on Western blots (5 h). In a semi-quantitative analysis, we rated the level of GAP-43 immunoreactivity from 0 (none) to 3 (intense) and correlated staining intensity with the length of the axon of the cell (150 -200 cells/condition). Inosine produced a highly significant increase in the number of cells with intensity Ͼ1 ( 2 ϭ 18.4; p Ͻ 0.0001), and the intensity of GAP-43 immunostaining was correlated with axon length (r ϭ 0.544; p Ͻ 0.0001). Appreciable levels of immunostaining were seen in 100% of inosine-treated cells having axons Ͼ5 cell diameters in length but in only 21% of inosine-treated cells with axons Ͻ5 cell diameters in length.
Blockade of Axonal Outgrowth with 6-TG-In PC12 cells and peripheral neurons, the purine analog 6-TG selectively blocks NGF-induced differentiation but not survival (26, 27) . Likewise, 6-TG (10 M) completely blocked AF-1-stimulated outgrowth in goldfish RGCs (Figs. 1d and 6a , lane 2; p Ͻ 0.001) with no effect on cell survival (Fig. 6b, lane 2) . This concentration of 6-TG reduced outgrowth stimulated by 25 M inosine by only 50% (Fig. 6a, lanes 4 versus lane 3) and had no effect on growth stimulated by 100 M inosine (or 100 M guanosine; Figs. 1g and 6a, lanes 5-8) . At 100 M, inosine restored the growth induced by AF-1 in the presence of 10 M 6-TG back to its original level (Figs. 1h and Fig. 6a, lane 10 versus lane 9) , which is significantly above the level induced by inosine alone (Fig. 6a, lane 10 versus lane 6, p Ͻ 0.01) . In additional studies, higher concentrations of 6-TG (200 M) completely blocked growth induced by 50 M inosine, whereas decreasing concen- trations of the inhibitor had progressively less of an effect (data not shown). Thus, inosine and 6-TG appear to compete for the same target molecule, and both of these modulate the effects of the endogenous growth factor AF-1.
Because 6-TG has a free thiol, it could be acting by nonspecific redox effects rather than as a purine analog. To test this possibility, we used a free radical scavenger, ␣-tocopherol (30 M), and glutathione ␣-methyl ester (100 M). Unlike 6-TG, these agents had no effect on outgrowth stimulated by AF-1 (Fig. 6d) . Another question was whether inosine might block the inhibitory effect of 6-TG on outgrowth by interfering with its transport into cells. This was investigated by examining whether the two transport inhibitors that block the positive effects of inosine would also block the negative effects of 6-TG. Neither NBTI (20 M) nor dipyridamole (10 M) prevented 6-TG from blocking outgrowth stimulated by AF-1 (Fig. 6d) .
Mammalian Retinal Ganglion Cells-Retinal ganglion cells, purified to homogeneity from 8-day-old rats, showed a modest level of spontaneous growth when grown in defined medium for 2 days (Fig. 7a) . Inosine at 25 M stimulated a 52% increase in outgrowth (p Ͻ 0.002 compared with controls; Fig. 7 , b and c, lane 2) but failed to alter cell survival (Fig. 7d) . A similar effect was seen with 50 M inosine, whereas 10 M was ineffective (not shown). CNTF induced a 3-fold increase in outgrowth over control levels (Fig. 7c, lane 3; cf. Ref. 17 ) and enhanced survival significantly. 10 M 6-TG blocked CNTF-induced outgrowth but did not prevent CNTF from enhancing cell survival (Fig. 7,  c and d, lane 5) . The addition of 50 M inosine restored a high level of outgrowth to CNTF-treated cells exposed to 6-TG (Fig.  7c, lane 6) .
Mitogen-activated Protein Kinase and PI 3-Kinase Pathways-In PC12 cells, activation of MEK-1 and/or MEK-2 is necessary and sufficient to induce neurite outgrowth (28, 29) . Conversely, PD 098059, which acts as a highly specific inhibitor of MEK-1/-2 activation (30, 32) , blocks NGF-induced differentiation of PC12 cells (31) . At 50 M, PD 098059 blocked ϳ50% of the outgrowth induced by 100 M inosine (p Ͻ 0.001) but did not alter the effects of AF-1 ( Fig. 8 ; similar results obtained in five separate experiments). PD 098059 at 25 M was equally effective in blocking growth stimulated by inosine, whereas at 100 M, it had a stronger effect on growth but also affected cell survival (data not shown). NGF signaling in PC12 cells also activates PI 3-kinase (33) , and inhibitors of this pathway also affect differentiation (34) . LY 294002, a potent phosphatidylinositol 3-kinase inhibitor (35) , showed similar effects as PD 098059, inhibiting about half the activity of 100 M inosine (p Ͻ 0.002) without affecting growth stimulated by AF-1 (Fig. 8) . The combination of PD 098059 plus LY 294002 completely blocked outgrowth stimulated by inosine (p Ͻ 0.001) but only partially diminished growth stimulated by AF-1 (loss significant at p Ͻ 0.002).
DISCUSSION
These results show that the purine nucleosides inosine and guanosine act through an intracellular mechanism to stimulate axonal outgrowth and GAP-43 expression in retinal ganglion cells. Inosine is the more potent of the two, perhaps because it preferentially activates one or more intracellular target(s) or perhaps because it is more readily converted to another active (lanes 3-6) irrespective of whether 6-TG is absent (lanes 3 and 4) or present (lanes 5 and 6) .
metabolite. It is clear that the nucleosides are not acting primarily as precursors to the cyclic nucleotides, however, because membrane-permeant, nonhydrolyzable analogs of cAMP and cGMP were inactive. The principle product of inosine hydrolysis, hypoxanthine, was likewise ineffective in causing growth, and hence the biologically active agent may be inosine per se. In other cell types, inosine acting through an intracellular mechanism has been shown to prevent cell death in astrocytes (36) and to evoke relaxation of the aorta (37) . In addition, inosine was shown to be the principal factor in liver conditioned medium that stimulates differentiation in chick sympathetic neurons (38) .
The intracellular target of inosine may coincide with a purine-sensitive kinase that has been implicated in mediating NGF-induced differentiation. In PC12 cells and in sensory and sympathetic neurons, the purine analog 6-TG blocks NGFinduced neurite outgrowth without affecting survival (26, 27) . Research into the mechanism of action of 6-TG has shown that it selectively inhibits an NGF-activated, 45-47-kDa serinethreonine kinase, protein kinase N (39, 40) , that remains to be characterized further. In the present study, a competition between inosine and 6-TG was evident; whereas outgrowth stimulated by a nearly saturating level of inosine was partially blocked by 6-TG at 10 M, outgrowth induced by higher concentrations of inosine (or guanosine) was not. However, increasing the concentration of 6-TG progressively inhibited the activity of higher concentrations of inosine. Hence, inosine may be acting as an agonist at the same site at which 6-TG acts as an antagonist, i.e. protein kinase N. The structural similarities among inosine, guanosine, and 6-TG would be consistent with a common site of action.
Growth induced by the endogenous low molecular mass factor AF-1 was more robust than by inosine and was more resistant to disruption by inhibitors of MEK-1/-2 and PI 3-kinase. Growth induced by inosine was reduced by half with the MEK-1/-2 inhibitor PD 098059 or by the PI 3-kinase inhibitor LY 294002 and was blocked completely by the combination of the two. In contrast, growth induced by AF-1 was unaffected by either inhibitor alone and still remained high in the presence of the two combined. On the other hand, growth stimulated by AF-1 was completely blocked by 6-TG, whereas inosine seemed to work competitively with 6-TG and restored AF-1-activated growth back to its original level in the presence of the inhibitor. One interpretation of these results is that growth stimulated by AF-1 and by inosine is transduced through protein kinase N but that AF-1 activates additional downstream pathways besides MEK-1/-2 and PI 3-kinase. Axon outgrowth in mammalian RGCs also appears to utilizes a purine-sensitive mechanism, because inosine stimulated some degree of outgrowth by itself and reversed the inhibition of CNTF-induced outgrowth by 6-TG. Throughout these studies, AF-1, inosine, nor 6-TG had any effect on cell survival. A similar dissociation between intracellular signaling pathways leading to survival versus outgrowth is well documented for other cell types (27, 29, 30) .
In vivo, optic nerve regeneration is marked by an increase in ganglion cells' expression of the membrane phosphoprotein GAP-43 (23, 24, 25, 41) . In goldfish RGCs, purines and AF-1 both stimulated GAP-43 expression, thus mimicking at least one aspect of the molecular changes that underlie axonal regeneration in vivo. In preliminary studies, inosine also strongly stimulated promoter activity for ␣-1 tubulin 3 and up-regulated expression of the cell adhesion molecule L1, 4 both of which are activated by regeneration in vivo.
Adenosine was active only when hydrolyzed to inosine. The nonhydrolyzable adenosine analog 2-CA failed to induce growth, whereas inhibiting the hydrolysis of adenosine itself led to diminished cell survival. Thus, the failure of adenosine to inhibit growth may be secondary to its effects on cell survival. Adenosine has previously been shown to induce apoptotic cell death in sensory neurons (13) and to inhibit in vitro regeneration of the frog sciatic nerve (42) . In PC12 cells, adenosine and its nucleotide derivatives potentiated NGF-induced outgrowth (12) . However, because inosine also had a positive effect in that study and because adenosine deaminase was not inhibited, it is possible that the stimulatory effects of the adenosine compounds all ultimately reflect the action of inosine. Positive effects of guanosine on neurite outgrowth in PC12 cells have also been reported recently (43) . In the present study, pyrimidine nucleosides had no effect on outgrowth, whereas the purine nucleotides showed only low levels of activity. Catabolic enzymes that rapidly convert cAMP, ATP, ADP, and AMP to adenosine are present extracellularly in cultured neurons (12, 44 -46) , and the low levels of activity found for 5Ј inosine monophosphate, 5Ј AMP, and ADP may therefore reflect their conversion to inosine. Adenosine, inosine, and guanosine coexist intracellularly, and it is even possible that purine nucleosides might act as second messengers in regulating the neuron's growth state. It will be of interest to identify the intracellular target(s) of the purines, whether it is protein kinase N or another molecule, and to characterize in detail the pathways that lead to axon growth.
